Rabies vaccine combination under development for human use

Such combination covers the globally innovative mRNA rabies vaccine under development, human diploid cell based rabies vaccine for human use as characterized by minimum inoculation, simple production technique, easy storage and stable quality as well as rabies vaccine for human use that uses serum free Vero cells. It features in higher safety and immunogenicity as well as less side effect.